EVFM 2018 Proxy Statement

16 EXECUTIVE OFFICER AND DIRECTOR COMPENSATION Prior to the Merger and as of December 31, 2017, our named executive officers, which consisted of our principal executive officer and our only other executive officer were: x Susan A. Knudson, Former Principal Executive Officer and Chief Financial Officer; and x Maria Feldman, Vice President, Clinical Operations, Regulatory Affairs and Quality Assurance. We have also included the principal executive officer and the two most highly compensated officers of Evofem Operations during 2017 below: x Saundra Pelletier, Chief Executive Officer (1) x Justin J. File, Chief Financial Officer (1) x Kelly Culwell, M.D., Chief Medical Officer (1) (1) Pursuant to the closing of the Merger, this individual became an executive officer of the Company in January 2018.